| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 40.10B | 39.53B | 36.67B | 35.44B | 31.45B | 30.02B |
| Gross Profit | 8.60B | 8.36B | 7.26B | 6.59B | 6.57B | 6.26B |
| EBITDA | 3.75B | 3.46B | 2.93B | 2.68B | 2.69B | 2.68B |
| Net Income | 2.53B | 2.93B | 1.84B | 1.12B | 2.18B | 1.81B |
Balance Sheet | ||||||
| Total Assets | 51.79B | 53.96B | 50.66B | 47.55B | 47.69B | 45.87B |
| Cash, Cash Equivalents and Short-Term Investments | 11.17B | 13.43B | 12.06B | 11.26B | 10.47B | 9.96B |
| Total Debt | 504.00M | 377.00M | 41.00M | 42.00M | 62.00M | 21.00M |
| Total Liabilities | 12.27B | 14.26B | 12.72B | 11.67B | 11.89B | 9.79B |
| Stockholders Equity | 39.37B | 39.56B | 37.81B | 35.75B | 35.71B | 36.07B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.59B | 1.34B | 755.00M | 750.00M | 1.08B |
| Operating Cash Flow | 0.00 | 4.79B | 3.11B | 1.82B | 1.39B | 3.07B |
| Investing Cash Flow | 0.00 | -5.69B | -228.00M | -214.00M | 157.00M | -117.00M |
| Financing Cash Flow | 0.00 | -1.35B | -906.00M | -1.81B | -2.40B | -1.65B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
83 Outperform | ¥128.62B | 15.30 | ― | 1.79% | 10.76% | 54.82% | |
78 Outperform | ¥173.56B | 9.78 | 10.24% | 2.43% | 6.08% | 8.55% | |
77 Outperform | ¥920.77B | 3.29 | 27.58% | 0.99% | 9.49% | 55.64% | |
76 Outperform | ¥29.61B | 14.12 | ― | 3.23% | 6.98% | -42.05% | |
66 Neutral | ¥116.91B | 17.53 | 2.80% | 3.38% | >-0.01% | -49.83% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
58 Neutral | ¥1.72T | 117.21 | 3.37% | 1.85% | -2.18% | 26.45% |